Syncona to buy Freeline Therapeutics
Freeline is a clinical-stage biotechnology company.
22 November 2023•2 mins read
Freeline is a clinical-stage biotechnology company.
AEA Investors-backed American Oncology Network inks $2.4bn sale to Cencora
7 minutes ago · 2 mins read
Warburg Pincus-backed Appasamy acquires German ophthalmic surgery firm Ruck
1 hour ago · 1 min read
New Harbor Capital’s LGM Pharma acquires contract lab Sannova Analytical
1 hour ago · 2 mins read
Amulet-backed TFP Fertility acquires Manchester Fertility Group in UK add-on
3 hours ago · 1 min read
Rubicon Technology Partners’ Procede Software acquires dealer software firm RIMSS
5 hours ago · 2 mins read
Oridian Capital-backed ACR picks up Ultra Green Packaging in 12th add-on
5 hours ago · 2 mins read
Inflexion agrees sale of majority Celnor stake to Goldman Sachs Alternatives
8 hours ago · 2 mins read
